SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-15-004403
Filing Date
2015-11-30
Accepted
2015-11-30 16:40:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SYNERGY PHARMACEUTICALS, INC. p15-2260sc13g.htm SC 13G 49179
  Complete submission text file 0000902664-15-004403.txt   51132
Mailing Address 40 WEST 57TH ST. 33RD FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 33RD FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

IRS No.: 133993048 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Subject) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86352 | Film No.: 151260370
SIC: 2834 Pharmaceutical Preparations